The question is whether this hike represents a market reaction or whether this hike is because of government created monopolies as has been the case with other pharmaceuticals, like for instance, Epipens?
Regardless it is interesting that the drug manufacturer was so close to the Clinton machine.
(From The Washington Free Beacon)
The head of a pharmaceutical company, who partnered with the Clinton Foundation, has increased the price of an auto-injector used to treat opioid overdoses by 680 percent over the course of three years.
Spencer Williamson, the president and chief executive officer of the Richmond, Virginia-based Kaleo Pharmaceuticals, is under fire after the price of a two-pack of Evzio, a device that treats life-threatening opioid overdoses, skyrocketed from $690 in 2014 to $4,500 today.